Cargando…
Reduction of LPAR1 Expression in Neuroblastoma Promotes Tumor Cell Migration
SIMPLE SUMMARY: The tumor metastasis in the bone marrow or other organs in high-risk neuroblastoma patients is a serious problem to tackle and strongly impairs the survival of patients. Novel and effective targets for the treatment of neuroblastoma, especially tumor metastasis, need to be explored....
Autores principales: | Liu, Xiangjun, Pei, Mengmiao, Yu, Yongbo, Wang, Xiaolin, Gui, Jingang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322936/ https://www.ncbi.nlm.nih.gov/pubmed/35884407 http://dx.doi.org/10.3390/cancers14143346 |
Ejemplares similares
-
Interleukin-15 enhanced the survival of human γδT cells by regulating the expression of Mcl-1 in neuroblastoma
por: Wang, Hui, et al.
Publicado: (2022) -
Massively Parallel Sequencing Reveals an Accumulation of De Novo Mutations and an Activating Mutation of LPAR1 in a Patient with Metastatic Neuroblastoma
por: Wei, Jun S., et al.
Publicado: (2013) -
Infiltration of LPAR5(+) macrophages in osteosarcoma tumor microenvironment predicts better outcomes
por: He, Yi, et al.
Publicado: (2022) -
In vivo collective cell migration requires an LPAR2-dependent increase in tissue fluidity
por: Kuriyama, Sei, et al.
Publicado: (2014) -
microRNA-329 reduces bone cancer pain through the LPAR1-dependent
LPAR1/ERK signal transduction pathway in mice
por: Wu, Xian-Ping, et al.
Publicado: (2019)